Back to KLRA

Royalty Pharma Sub-Manager, LLC → KLRA

Royalty Pharma Sub-Manager, LLC KLRA Position History

Kailera Therapeutics, Inc. • Healthcare

Quarters held
2
Latest value
$54.1M
Q2 2026
Peak value
$54.1M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$54.1M
Q2 2026$54.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$54.1M2.46M——
Q2 2026$54.1M2.46M——

Other funds holding KLRA

Other Royalty Pharma Sub-Manager, LLC positions

CYTK

CYTOKINETICS, INC

$83.5M
CYTK

CYTOKINETICS, INC

$83.5M
CYTK

CYTOKINETICS, INC

$64.6M
CYTK

CYTOKINETICS, INC

$64.6M
CYTK

CYTOKINETICS, INC

$62.3M
CYTK

CYTOKINETICS, INC

$62.3M
BCAX

ZENAS BIOPHARMA, INC.

$60.6M
ZBIO

ZENAS BIOPHARMA, INC.

$60.6M